A study introduces a scalable 2D human neuron platform to probe how brain-like rhythms emerge and how specific drugs reshape them, aiding epilepsy and autism research.
Morning Overview on MSN
How science and luck sparked a radical new era in schizophrenia treatment
The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
AHARA Mushrooms today published the results of the most comprehensive metabolomic analysis ever conducted on a mushroom ...
New drugs were approved for the oncology field, and for treating ophthalmic, gastrohepatic, hemologic, and metabolic disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results